<div id="readability-page-1"><div><ul> <li>Bunge Global SA reported past first-quarter 2026 results, with sales rising to US$21.86 billion from US$11.64 billion a year earlier, while net income fell to US$68 million from US$201 million and diluted EPS from continuing operations declined to US$0.35 from US$1.48.</li> <li>This combination of very large revenue growth alongside weaker profitability highlights how cost pressures, mix shifts, or integration effects can materially affect the company’s earnings power despite higher volumes.</li> <li>We’ll now examine how this sharp revenue increase but lower earnings in the latest quarter may influence Bunge Global’s existing investment narrative.</li> </ul><p>We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.</p><h2>Bunge Global Investment Narrative Recap</h2><p>To own Bunge Global today, you need to believe in its role as a scaled connector of global crops to food, feed and fuel demand, while successfully integrating Viterra and managing policy and commodity volatility. The latest quarter’s sharp revenue jump but weaker earnings keeps that core story intact, but it underlines that the biggest near term catalyst, Viterra integration benefits, sits alongside a key risk that cost pressures and integration expenses keep eroding margins.</p> <p>Against this backdrop, the recently affirmed quarterly dividend of US$0.72 per share through early 2027 stands out. It signals that, despite thinner profits in the latest results, management has so far chosen to maintain a consistent capital return framework, which matters if you see the integration and heavy investment cycle as a temporary drag rather than a structural reset to Bunge’s earnings power.</p> <p>Yet behind the headline revenue surge, one risk in particular may quietly matter more for investors…</p> <p>Read the full narrative on Bunge Global (it's free!)</p><p>Bunge Global’s narrative projects $93.9 billion revenue and $2.5 billion earnings by 2029. This requires 10.1% yearly revenue growth and about a $1.7 billion earnings increase from $819.0 million today.</p><p>Uncover how Bunge Global's forecasts yield a $135.56 fair value, a 7% upside to its current price.</p><h2>Exploring Other Perspectives</h2><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b802d7a4-fc4c-42f6-9de2-ad1dcce797ac/chart/quote-price?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b802d7a4-fc4c-42f6-9de2-ad1dcce797ac/chart/quote-price"/><figcaption>BG 1-Year Stock Price Chart</figcaption></figure> <p>Some of the most optimistic analysts were expecting Bunge to reach about US$96.4 billion of revenue and US$2.9 billion of earnings by 2029, so this weak-profit quarter may prompt you to reconsider how much integration and margin pressure you think is already reflected in those bullish forecasts and whether your own expectations should sit closer to or further from that optimistic camp.</p><p>Explore 2 other fair value estimates on Bunge Global - why the stock might be worth just $135.56!</p><h2>Form Your Own Verdict</h2><p>Don't just follow the ticker - dig into the data and build a conviction that's truly your own.</p><ul><li>A great starting point for your Bunge Global research is our analysis highlighting 2 key rewards and 4 important warning signs that could impact your investment decision.</li><li>Our free Bunge Global research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Bunge Global's overall financial health at a glance.</li></ul><h2>Want Some Alternatives?</h2><p>Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:</p><ul><li>Uncover the next big thing with 26 elite penny stocks that balance risk and reward.</li><li>Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.</li><li>The future of work is here. Discover the 31 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data     and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your     financial situation. We aim to bring you long-term focused analysis driven by fundamental data.     Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.     Simply Wall St has no position in any stocks mentioned.</em></p><div><h3>Valuation is complex, but we're here to simplify it.</h3><p>Discover if Bunge Global might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><p>Access Free Analysis</p></div></div></div>

VEGI

FTAG

<p>Bunge Global SA reported a significant revenue increase to US$21.86 billion in Q1 2026, up from US$11.64 billion a year prior. However, net income fell to US$68 million from US$201 million, indicating weaker profitability despite higher sales. This situation raises concerns about cost pressures and integration expenses affecting margins. The company maintains a quarterly dividend of US$0.72 per share, signaling confidence in its investment strategy. Analysts project a revenue of $93.9 billion and earnings of $2.5 billion by 2029, but recent results may prompt a reevaluation of these optimistic forecasts.</p>

Simplywall

Bunge Global SA

How Surging Sales But Weaker Margins At Bunge Global (BG) Has Changed Its Investment Story